Optimal lipofection reagent varies with the molecular modifications of the DNA

被引:15
作者
Conrad, AH
Behlke, MA
Jaffredo, T
Conrad, GW
机构
[1] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA
[2] Integrated DNA Technol Inc, Coralville, IA 52241 USA
[3] Coll France, Inst Embryol Cellulaire & Mol, F-94736 Nogent Sur Marne, France
[4] CNRS, Inst Embryol Cellulaire & Mol, F-94736 Nogent Sur Marne, France
来源
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT | 1998年 / 8卷 / 05期
关键词
D O I
10.1089/oli.1.1998.8.427
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cationic lipid reagents differ in their cytofection efficacy with different cell types. No evidence has addressed whether the same lipid reagent is best for different DNAs in a single cell line. Immortalized avian embryonic cardiomyocytes cultured in vitro were tested with 15 cationic lipid reagents using (A) a beta-gal expression plasmid, (B) a fluorescein-tagged, phosphorothioate-modified ODN B, (C) a fluorescein-tagged, ethoxy-modified ODN C with the same nucleotide sequence as ODN B, and (D) a fluorescein-tagged, phosphorothioate-modified ODN D with a different nucleotide sequence from ODNs B and C. Cytofection was scored as percent of cells expressing beta-gal activity or showing diffuse cellular fluorescence. The best lipid reagents for the phosphorothioate-modified ODNs were ODN-specific and markedly different from the best Lipid reagents for the expression plasmid or for the ethoxy-modified ODN. These results suggest that the best cationic Lipid reagent for a particular cell type varies with the physical and chemical form of the DNA being transfected into the cells.
引用
收藏
页码:427 / 434
页数:8
相关论文
共 37 条
[1]   SITE-SPECIFIC EXCISION FROM RNA BY RNASE-H AND MIXED-PHOSPHATE-BACKBONE OLIGODEOXYNUCLEOTIDES [J].
AGRAWAL, S ;
MAYRAND, SH ;
ZAMECNIK, PC ;
PEDERSON, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (04) :1401-1405
[2]   Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: In vitro and in vivo studies [J].
Agrawal, S ;
Jiang, ZW ;
Zhao, QY ;
Shaw, D ;
Cai, QY ;
Roskey, A ;
Channavajjala, L ;
Saxinger, C ;
Zhang, RW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) :2620-2625
[3]   ANTISENSE INHIBITION OF ENGRAILED GENES IN MOUSE EMBRYOS REVEALS ROLES FOR THESE GENES IN CRANIOFACIAL AND NEURAL-TUBE DEVELOPMENT [J].
AUGUSTINE, KA ;
LIU, ET ;
SADLER, TW .
TERATOLOGY, 1995, 51 (05) :300-310
[4]   BINDING, UPTAKE, AND INTRACELLULAR TRAFFICKING OF PHOSPHOROTHIOATE-MODIFIED OLIGODEOXYNUCLEOTIDES [J].
BELTINGER, C ;
SARAGOVI, HU ;
SMITH, RM ;
LESAUTEUR, L ;
SHAH, N ;
DEDIONISIO, L ;
CHRISTENSEN, L ;
RAIBLE, A ;
JARETT, L ;
GEWIRTZ, AM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (04) :1814-1823
[5]  
BENNETT CF, 1992, MOL PHARMACOL, V41, P1023
[6]  
Bennett CF, 1997, J PHARMACOL EXP THER, V280, P988
[7]   Electroporation of synthetic oligodeoxynucleotides: A novel technique for ex vivo bone marrow purging [J].
Bergan, R ;
Hakim, F ;
Schwartz, GN ;
Kyle, E ;
Cepada, R ;
Szabo, JM ;
Fowler, D ;
Gress, R ;
Neckers, L .
BLOOD, 1996, 88 (02) :731-741
[8]  
Cook P.D., 1993, ANTISENSE RES APPL, P149
[9]   TARGETED DEGRADATION OF MESSENGER-RNA IN XENOPUS OOCYTES AND EMBRYOS DIRECTED BY MODIFIED OLIGONUCLEOTIDES - STUDIES OF AN2 AND CYCLIN IN EMBRYOGENESIS [J].
DAGLE, JM ;
WALDER, JA ;
WEEKS, DL .
NUCLEIC ACIDS RESEARCH, 1990, 18 (16) :4751-4757
[10]   SONIC-HEDGEHOG, A MEMBER OF A FAMILY OF PUTATIVE SIGNALING MOLECULES, IS IMPLICATED IN THE REGULATION OF CNS POLARITY [J].
ECHELARD, Y ;
EPSTEIN, DJ ;
STJACQUES, B ;
SHEN, L ;
MOHLER, J ;
MCMAHON, JA ;
MCMAHON, AP .
CELL, 1993, 75 (07) :1417-1430